Nob Hill Therapeutics has filed a notice of an exempt offering of securities to raise $3,850,649.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Nob Hill Therapeutics is raising up to $3,850,649.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Noel Greenberger played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Nob Hill Therapeutics
Nob Hill Therapeutics mission is to commercialize the first of its kind dry powder nebulizer (DryNebTM ) inhalation drug delivery platform. NHT is focused on creating effective inhalation therapies to address lower respiratory tract infections (the 5th leading overall cause of death worldwide) and other deadly lung diseases.
To learn more about Nob Hill Therapeutics, visit http://nobhilltherapeutics.com/
Nob Hill Therapeutics Linkedin Page: https://www.linkedin.com/company/nob-hill-therapeutics/
Contact:
Noel Greenberger, Chief Executive Officer
858-356-9158
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.